Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents

Glioblastoma (GBM) is the most aggressive adult brain tumour with a dismal 2-year survival rate of 26–33%. Maximal safe resection plays a crucial role in improving patient progression-free survival (PFS). Neurosurgeons have the significant challenge of delineating normal tissue from brain tumour to...

Descripción completa

Detalles Bibliográficos
Autores principales: Netufo, Oluwakanyinsolami, Connor, Kate, Shiels, Liam P., Sweeney, Kieron J., Wu, Dan, O’Shea, Donal F., Byrne, Annette T., Miller, Ian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143023/
https://www.ncbi.nlm.nih.gov/pubmed/35631376
http://dx.doi.org/10.3390/ph15050550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143023/
https://www.ncbi.nlm.nih.gov/pubmed/35631376
http://dx.doi.org/10.3390/ph15050550

Ejemplares similares